Adherence to geriatric-assessment-based guidelines and associated survival outcomes in older patients with prostate cancer: the ELCAPA-26 prospective multicentre cohort study

2021 ◽  
Vol 12 (8) ◽  
pp. S71-S72
Author(s):  
A. Gonzalez Serrano ◽  
C. Martínez Tapia ◽  
A. de la Taille ◽  
P. Mongiat-Artus ◽  
J. Irani ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cohort Study ◽  
Geriatric Assessment ◽  
Older Patients ◽  
Survival Outcomes ◽  
Multicentre Cohort Study ◽  
Multicentre Cohort

scholarly journals REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

2019 ◽  
Vol 138 ◽  
pp. 59-67 ◽  
Author(s):  
Petra Seibold ◽  
Adam Webb ◽  
Miguel E. Aguado-Barrera ◽  
David Azria ◽  
Celine Bourgier ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cohort Study ◽  
Multicentre Cohort Study ◽  
Multicentre Cohort

scholarly journals Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study

2017 ◽  
Vol 24 (11) ◽  
pp. 982-989 ◽  
Author(s):  
S. Mgaieth ◽  
W. Kemp ◽  
P. Gow ◽  
M. Fink ◽  
J. Lubel ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cohort Study ◽  
Viral Hepatitis ◽  
Survival Outcomes ◽  
Multicentre Cohort Study ◽  
Multicentre Cohort

Real-life implementation and survival outcomes of geriatric-assessement-based guidelines for treatment decision in older patients with prostate cancer: The ELCAPA-26 cohort study

2021 ◽  
Vol 79 ◽  
pp. S474
Author(s):  
A. González Serrano ◽  
C. Martinez Tapia ◽  
A. De La Taille ◽  
P. Mongiat-Artus ◽  
J. Irani ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cohort Study ◽  
Older Patients ◽  
Real Life ◽  
Treatment Decision ◽  
Survival Outcomes

scholarly journals Age differences in clinical features and outcomes in patients with COVID-19, Jiangsu, China: a retrospective, multicentre cohort study

BMJ Open ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. e039887 ◽  
Author(s):  
Huanyuan Luo ◽  
Songqiao Liu ◽  
Yuancheng Wang ◽  
Penelope A Phillips-Howard ◽  
Shenghong Ju ◽  
...  
Keyword(s):  
Cohort Study ◽  
Intensive Care ◽  
Respiratory Failure ◽  
Hospital Stay ◽  
Older Patients ◽  
Adverse Outcomes ◽  
Trend Test ◽  
Chronic Obstructive ◽  
Multicentre Cohort Study ◽  
Multicentre Cohort

ObjectivesTo determine the age-specific clinical presentations and incidence of adverse outcomes among patients with COVID-19 in Jiangsu, China.Design and settingRetrospective, multicentre cohort study performed at 24 hospitals in Jiangsu, China.Participants625 patients with COVID-19 enrolled between 10 January and 15 March 2020.ResultsOf the 625 patients (median age, 46 years; 329 (52.6%) men), 37 (5.9%) were children (18 years or younger), 261 (41.8%) young adults (19–44 years), 248 (39.7%) middle-aged adults (45–64 years) and 79 (12.6%) elderly adults (65 years or older). The incidence of hypertension, coronary heart disease, chronic obstructive pulmonary disease and diabetes comorbidities increased with age (trend test, p<0.0001, p=0.0003, p<0.0001 and p<0.0001, respectively). Fever, cough and shortness of breath occurred more commonly among older patients, especially the elderly, compared with children (χ2 test, p=0.0008, 0.0146 and 0.0282, respectively). The quadrant score and pulmonary opacity score increased with age (trend test, both p<0.0001). Older patients had many significantly different laboratory parameters from younger patients. Elderly patients had the highest proportion of severe or critically-ill cases (33.0%, χ2 test p<0.0001), intensive care unit use (35.4%, χ2 test p<0.0001), respiratory failure (31.6%, χ2 test p<0.0001) and the longest hospital stay (median 21 days, Kruskal–Wallis test p<0.0001).ConclusionsElderly (≥65 years) patients with COVID-19 had the highest risk of severe or critical illness, intensive care use, respiratory failure and the longest hospital stay, which may be due partly to their having a higher incidence of comorbidities and poor immune responses to COVID-19.

Sign in / Sign up

Export Citation Format

Share Document